Review




Structured Review

Proteintech gramd4
Gramd4, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gramd4/product/Proteintech
Average 93 stars, based on 3 article reviews
gramd4 - by Bioz Stars, 2026-02
93/100 stars

Images



Similar Products

92
Thermo Fisher copy number variation gramd4 mm00423060 cn
Copy Number Variation Gramd4 Mm00423060 Cn, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/copy number variation gramd4 mm00423060 cn/product/Thermo Fisher
Average 92 stars, based on 1 article reviews
copy number variation gramd4 mm00423060 cn - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

93
Proteintech gramd4
Gramd4, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gramd4/product/Proteintech
Average 93 stars, based on 1 article reviews
gramd4 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

93
Proteintech domain death agonist
Figure 2. Electroacupuncture (EA) protected neurons against spinal cord injury (SCI)-induced apoptosis. Tissues were obtained and processed as described for Fig. 1 and in Methods. A. Nissl staining of spinal cord. Upper panel shows full cross sections of spinal cord, scale bar = 500 μm. Lower panel shows partial enlargement of sections, scale bar = 50 μm; B. Representative images showing immunofluo- rescence of TUNEL+/NeuN+ in rat spinal cord, scale bar = 50 μm; C. Quantification of percentage of TUNEL and NeuN dual-positive cells in spinal cord; D. Left panel shows immune blots of B-cell lymphoma-2 associated X protein (Bax), BH3-interacting <t>domain</t> <t>death</t> <t>agonist</t> (Bid), and B-cell lymphoma-2 (Bcl-2). Right panel shows quantification of Bax, Bid, and Bcl-2 protein expression in lysates of spinal cord. Numeric data refers to Figs. 2C, D, results expressed as mean ± standard deviation, n = 6 in each group. *P < 0.05, **P < 0.01, ***P < 0.001, API — 4’,6-diamidino-2-phenylindole; Ns — not significant.
Domain Death Agonist, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/domain death agonist/product/Proteintech
Average 93 stars, based on 1 article reviews
domain death agonist - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

88
Santa Cruz Biotechnology anti gramd4 antibody
(A) Manhattan plot showing all splice variant SNPs across the 49 phenotypes. For each splice variant, the best p value observed among all assessed traits is plotted on a –log10 scale (y axis), according to its genomic coordinates (x axis). <t>Gramd4</t> splice variant chosen for validation is highlighted in red. (B) Variation in frequency of BM pre-cDCs in C57BL/6J (gray; n = 3), 129 (pink; n = 3), NOD (blue; n = 3), NZO (cyan; n = 3), A/J (yellow; n = 3), WSB (purple; n = 3), DO (black; n = 170), and CC-RI (open; n = 47) mice. (C) A QTL driving the frequency of BM pre-cDCs found within chromosome 15 (chr15:86,581,607, LOD = 10.7) that appears to be driven by an A/J and NZO founder effect. (D) Gramd4 gene structure and schematic representation of alternative splicing (UCSC Genome Browser). SNP localization is shown in red. (E) Western blot on total splenocytes from Gramd4 w/w and Gramd4 sp/sp mice showing alternative splicing. (F) Schematic representation of mixed BM chimera experiment. (G) Representative flow cytometry plot for mixed BM experiment. (H) Frequencies of DC progenitors and subsets in mixed BM chimera mice due to differential expression of Gramd4 SNP variant in BM, spleen, and inguinal LN. Chimerism is expressed as the ratio between the number of CD45.2 and CD45.1/CD45.2 cells for each cell population. Representative of 2 independent experiments; each dot represents one mouse, n = 6 per group, Gramd4 w/w (red) and Gramd4 sp/sp (blue), and horizontal lines represent means. (I) Schematic representation of the experimental setup in (J) and (K). (J) Representative flow cytometry plot for OT-II CD4 + T cell activation (CTV dilution after immunization with OVA 328–339 peptide in alum) in popliteal LN of Gramd4 w/w and Gramd4 sp/sp recipient mice. Graph shows the absolute numbers of OT-II cells in popliteal lymph nodes and the x axis the number of divisions after immunization. (K) CD69 and CD43 expression of divided OT-II T cells in popliteal LN of Gramd4 w/w and Gramd4 sp/sp recipient mice. Each dot represents one mouse, n = 6 per group, Gramd4 w/w (orange) and Gramd4 sp/sp (green), and horizontal lines represent means (J and K). Student’s t test, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. iLN (inguinal LN).
Anti Gramd4 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti gramd4 antibody/product/Santa Cruz Biotechnology
Average 88 stars, based on 1 article reviews
anti gramd4 antibody - by Bioz Stars, 2026-02
88/100 stars
  Buy from Supplier

88
Santa Cruz Biotechnology gramd4 antibody clone c 8
(A) Manhattan plot showing all splice variant SNPs across the 49 phenotypes. For each splice variant, the best p value observed among all assessed traits is plotted on a –log10 scale (y axis), according to its genomic coordinates (x axis). <t>Gramd4</t> splice variant chosen for validation is highlighted in red. (B) Variation in frequency of BM pre-cDCs in C57BL/6J (gray; n = 3), 129 (pink; n = 3), NOD (blue; n = 3), NZO (cyan; n = 3), A/J (yellow; n = 3), WSB (purple; n = 3), DO (black; n = 170), and CC-RI (open; n = 47) mice. (C) A QTL driving the frequency of BM pre-cDCs found within chromosome 15 (chr15:86,581,607, LOD = 10.7) that appears to be driven by an A/J and NZO founder effect. (D) Gramd4 gene structure and schematic representation of alternative splicing (UCSC Genome Browser). SNP localization is shown in red. (E) Western blot on total splenocytes from Gramd4 w/w and Gramd4 sp/sp mice showing alternative splicing. (F) Schematic representation of mixed BM chimera experiment. (G) Representative flow cytometry plot for mixed BM experiment. (H) Frequencies of DC progenitors and subsets in mixed BM chimera mice due to differential expression of Gramd4 SNP variant in BM, spleen, and inguinal LN. Chimerism is expressed as the ratio between the number of CD45.2 and CD45.1/CD45.2 cells for each cell population. Representative of 2 independent experiments; each dot represents one mouse, n = 6 per group, Gramd4 w/w (red) and Gramd4 sp/sp (blue), and horizontal lines represent means. (I) Schematic representation of the experimental setup in (J) and (K). (J) Representative flow cytometry plot for OT-II CD4 + T cell activation (CTV dilution after immunization with OVA 328–339 peptide in alum) in popliteal LN of Gramd4 w/w and Gramd4 sp/sp recipient mice. Graph shows the absolute numbers of OT-II cells in popliteal lymph nodes and the x axis the number of divisions after immunization. (K) CD69 and CD43 expression of divided OT-II T cells in popliteal LN of Gramd4 w/w and Gramd4 sp/sp recipient mice. Each dot represents one mouse, n = 6 per group, Gramd4 w/w (orange) and Gramd4 sp/sp (green), and horizontal lines represent means (J and K). Student’s t test, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. iLN (inguinal LN).
Gramd4 Antibody Clone C 8, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gramd4 antibody clone c 8/product/Santa Cruz Biotechnology
Average 88 stars, based on 1 article reviews
gramd4 antibody clone c 8 - by Bioz Stars, 2026-02
88/100 stars
  Buy from Supplier

88
Santa Cruz Biotechnology western blot membrane
(A) Manhattan plot showing all splice variant SNPs across the 49 phenotypes. For each splice variant, the best p value observed among all assessed traits is plotted on a –log10 scale (y axis), according to its genomic coordinates (x axis). <t>Gramd4</t> splice variant chosen for validation is highlighted in red. (B) Variation in frequency of BM pre-cDCs in C57BL/6J (gray; n = 3), 129 (pink; n = 3), NOD (blue; n = 3), NZO (cyan; n = 3), A/J (yellow; n = 3), WSB (purple; n = 3), DO (black; n = 170), and CC-RI (open; n = 47) mice. (C) A QTL driving the frequency of BM pre-cDCs found within chromosome 15 (chr15:86,581,607, LOD = 10.7) that appears to be driven by an A/J and NZO founder effect. (D) Gramd4 gene structure and schematic representation of alternative splicing (UCSC Genome Browser). SNP localization is shown in red. (E) Western blot on total splenocytes from Gramd4 w/w and Gramd4 sp/sp mice showing alternative splicing. (F) Schematic representation of mixed BM chimera experiment. (G) Representative flow cytometry plot for mixed BM experiment. (H) Frequencies of DC progenitors and subsets in mixed BM chimera mice due to differential expression of Gramd4 SNP variant in BM, spleen, and inguinal LN. Chimerism is expressed as the ratio between the number of CD45.2 and CD45.1/CD45.2 cells for each cell population. Representative of 2 independent experiments; each dot represents one mouse, n = 6 per group, Gramd4 w/w (red) and Gramd4 sp/sp (blue), and horizontal lines represent means. (I) Schematic representation of the experimental setup in (J) and (K). (J) Representative flow cytometry plot for OT-II CD4 + T cell activation (CTV dilution after immunization with OVA 328–339 peptide in alum) in popliteal LN of Gramd4 w/w and Gramd4 sp/sp recipient mice. Graph shows the absolute numbers of OT-II cells in popliteal lymph nodes and the x axis the number of divisions after immunization. (K) CD69 and CD43 expression of divided OT-II T cells in popliteal LN of Gramd4 w/w and Gramd4 sp/sp recipient mice. Each dot represents one mouse, n = 6 per group, Gramd4 w/w (orange) and Gramd4 sp/sp (green), and horizontal lines represent means (J and K). Student’s t test, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. iLN (inguinal LN).
Western Blot Membrane, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/western blot membrane/product/Santa Cruz Biotechnology
Average 88 stars, based on 1 article reviews
western blot membrane - by Bioz Stars, 2026-02
88/100 stars
  Buy from Supplier

Image Search Results


Figure 2. Electroacupuncture (EA) protected neurons against spinal cord injury (SCI)-induced apoptosis. Tissues were obtained and processed as described for Fig. 1 and in Methods. A. Nissl staining of spinal cord. Upper panel shows full cross sections of spinal cord, scale bar = 500 μm. Lower panel shows partial enlargement of sections, scale bar = 50 μm; B. Representative images showing immunofluo- rescence of TUNEL+/NeuN+ in rat spinal cord, scale bar = 50 μm; C. Quantification of percentage of TUNEL and NeuN dual-positive cells in spinal cord; D. Left panel shows immune blots of B-cell lymphoma-2 associated X protein (Bax), BH3-interacting domain death agonist (Bid), and B-cell lymphoma-2 (Bcl-2). Right panel shows quantification of Bax, Bid, and Bcl-2 protein expression in lysates of spinal cord. Numeric data refers to Figs. 2C, D, results expressed as mean ± standard deviation, n = 6 in each group. *P < 0.05, **P < 0.01, ***P < 0.001, API — 4’,6-diamidino-2-phenylindole; Ns — not significant.

Journal: Folia histochemica et cytobiologica

Article Title: Electroacupuncture stimulation inhibited astrogliosis and microglia polarisation to alleviate spinal cord injury via Janus kinase 2/signal transducer and activator of transcription 3 signalling pathway.

doi: 10.5603/fhc.104273

Figure Lengend Snippet: Figure 2. Electroacupuncture (EA) protected neurons against spinal cord injury (SCI)-induced apoptosis. Tissues were obtained and processed as described for Fig. 1 and in Methods. A. Nissl staining of spinal cord. Upper panel shows full cross sections of spinal cord, scale bar = 500 μm. Lower panel shows partial enlargement of sections, scale bar = 50 μm; B. Representative images showing immunofluo- rescence of TUNEL+/NeuN+ in rat spinal cord, scale bar = 50 μm; C. Quantification of percentage of TUNEL and NeuN dual-positive cells in spinal cord; D. Left panel shows immune blots of B-cell lymphoma-2 associated X protein (Bax), BH3-interacting domain death agonist (Bid), and B-cell lymphoma-2 (Bcl-2). Right panel shows quantification of Bax, Bid, and Bcl-2 protein expression in lysates of spinal cord. Numeric data refers to Figs. 2C, D, results expressed as mean ± standard deviation, n = 6 in each group. *P < 0.05, **P < 0.01, ***P < 0.001, API — 4’,6-diamidino-2-phenylindole; Ns — not significant.

Article Snippet: The PVDF membrane was blocked with a membrane sealing solution (Solarbio) at RT for 1 h. Primary antibodies [B-cell lymphoma-2 (Bcl-2; 1:1,000, Proteintech), BH3-interacting domain death agonist (Bid; 1:1,500, Proteintech), B-cell lymphoma-2 associated X protein (Bax; 1:5,000, Proteintech), JAK2 (1:1,500, Affinity), STAT3 (1:2,000, Proteintech), Phospho-JAK2 (p-JAK2; 1:800, ABclonal, Wuhan, China), p-STAT3 (1:1,000, Affinity), and glyceraldehyde phosphate dehydrogenase (GAPDH; 1:10,000, Proteintech)] were incubated with the PVDF membranes overnight at 4°C and washed with Tris-buffered saline with tween-20 (TBS-T) buffer.

Techniques: Staining, TUNEL Assay, Expressing, Standard Deviation

(A) Manhattan plot showing all splice variant SNPs across the 49 phenotypes. For each splice variant, the best p value observed among all assessed traits is plotted on a –log10 scale (y axis), according to its genomic coordinates (x axis). Gramd4 splice variant chosen for validation is highlighted in red. (B) Variation in frequency of BM pre-cDCs in C57BL/6J (gray; n = 3), 129 (pink; n = 3), NOD (blue; n = 3), NZO (cyan; n = 3), A/J (yellow; n = 3), WSB (purple; n = 3), DO (black; n = 170), and CC-RI (open; n = 47) mice. (C) A QTL driving the frequency of BM pre-cDCs found within chromosome 15 (chr15:86,581,607, LOD = 10.7) that appears to be driven by an A/J and NZO founder effect. (D) Gramd4 gene structure and schematic representation of alternative splicing (UCSC Genome Browser). SNP localization is shown in red. (E) Western blot on total splenocytes from Gramd4 w/w and Gramd4 sp/sp mice showing alternative splicing. (F) Schematic representation of mixed BM chimera experiment. (G) Representative flow cytometry plot for mixed BM experiment. (H) Frequencies of DC progenitors and subsets in mixed BM chimera mice due to differential expression of Gramd4 SNP variant in BM, spleen, and inguinal LN. Chimerism is expressed as the ratio between the number of CD45.2 and CD45.1/CD45.2 cells for each cell population. Representative of 2 independent experiments; each dot represents one mouse, n = 6 per group, Gramd4 w/w (red) and Gramd4 sp/sp (blue), and horizontal lines represent means. (I) Schematic representation of the experimental setup in (J) and (K). (J) Representative flow cytometry plot for OT-II CD4 + T cell activation (CTV dilution after immunization with OVA 328–339 peptide in alum) in popliteal LN of Gramd4 w/w and Gramd4 sp/sp recipient mice. Graph shows the absolute numbers of OT-II cells in popliteal lymph nodes and the x axis the number of divisions after immunization. (K) CD69 and CD43 expression of divided OT-II T cells in popliteal LN of Gramd4 w/w and Gramd4 sp/sp recipient mice. Each dot represents one mouse, n = 6 per group, Gramd4 w/w (orange) and Gramd4 sp/sp (green), and horizontal lines represent means (J and K). Student’s t test, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. iLN (inguinal LN).

Journal: Cell reports

Article Title: Quantitative trait loci mapping provides insights into the genetic regulation of dendritic cell numbers in mouse tissues

doi: 10.1016/j.celrep.2024.114296

Figure Lengend Snippet: (A) Manhattan plot showing all splice variant SNPs across the 49 phenotypes. For each splice variant, the best p value observed among all assessed traits is plotted on a –log10 scale (y axis), according to its genomic coordinates (x axis). Gramd4 splice variant chosen for validation is highlighted in red. (B) Variation in frequency of BM pre-cDCs in C57BL/6J (gray; n = 3), 129 (pink; n = 3), NOD (blue; n = 3), NZO (cyan; n = 3), A/J (yellow; n = 3), WSB (purple; n = 3), DO (black; n = 170), and CC-RI (open; n = 47) mice. (C) A QTL driving the frequency of BM pre-cDCs found within chromosome 15 (chr15:86,581,607, LOD = 10.7) that appears to be driven by an A/J and NZO founder effect. (D) Gramd4 gene structure and schematic representation of alternative splicing (UCSC Genome Browser). SNP localization is shown in red. (E) Western blot on total splenocytes from Gramd4 w/w and Gramd4 sp/sp mice showing alternative splicing. (F) Schematic representation of mixed BM chimera experiment. (G) Representative flow cytometry plot for mixed BM experiment. (H) Frequencies of DC progenitors and subsets in mixed BM chimera mice due to differential expression of Gramd4 SNP variant in BM, spleen, and inguinal LN. Chimerism is expressed as the ratio between the number of CD45.2 and CD45.1/CD45.2 cells for each cell population. Representative of 2 independent experiments; each dot represents one mouse, n = 6 per group, Gramd4 w/w (red) and Gramd4 sp/sp (blue), and horizontal lines represent means. (I) Schematic representation of the experimental setup in (J) and (K). (J) Representative flow cytometry plot for OT-II CD4 + T cell activation (CTV dilution after immunization with OVA 328–339 peptide in alum) in popliteal LN of Gramd4 w/w and Gramd4 sp/sp recipient mice. Graph shows the absolute numbers of OT-II cells in popliteal lymph nodes and the x axis the number of divisions after immunization. (K) CD69 and CD43 expression of divided OT-II T cells in popliteal LN of Gramd4 w/w and Gramd4 sp/sp recipient mice. Each dot represents one mouse, n = 6 per group, Gramd4 w/w (orange) and Gramd4 sp/sp (green), and horizontal lines represent means (J and K). Student’s t test, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. iLN (inguinal LN).

Article Snippet: After being blocked, the western blot membrane was subsequently incubated with anti-Gramd4 antibody (Clone C-8, Santa-Cruz).

Techniques: Variant Assay, Biomarker Discovery, Alternative Splicing, Western Blot, Flow Cytometry, Quantitative Proteomics, Activation Assay, Expressing

KEY RESOURCES TABLE

Journal: Cell reports

Article Title: Quantitative trait loci mapping provides insights into the genetic regulation of dendritic cell numbers in mouse tissues

doi: 10.1016/j.celrep.2024.114296

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: After being blocked, the western blot membrane was subsequently incubated with anti-Gramd4 antibody (Clone C-8, Santa-Cruz).

Techniques: Marker, Staining, Recombinant, Red Blood Cell Lysis, Software

(A) Manhattan plot showing all splice variant SNPs across the 49 phenotypes. For each splice variant, the best p value observed among all assessed traits is plotted on a –log10 scale (y axis), according to its genomic coordinates (x axis). Gramd4 splice variant chosen for validation is highlighted in red. (B) Variation in frequency of BM pre-cDCs in C57BL/6J (gray; n = 3), 129 (pink; n = 3), NOD (blue; n = 3), NZO (cyan; n = 3), A/J (yellow; n = 3), WSB (purple; n = 3), DO (black; n = 170), and CC-RI (open; n = 47) mice. (C) A QTL driving the frequency of BM pre-cDCs found within chromosome 15 (chr15:86,581,607, LOD = 10.7) that appears to be driven by an A/J and NZO founder effect. (D) Gramd4 gene structure and schematic representation of alternative splicing (UCSC Genome Browser). SNP localization is shown in red. (E) Western blot on total splenocytes from Gramd4 w/w and Gramd4 sp/sp mice showing alternative splicing. (F) Schematic representation of mixed BM chimera experiment. (G) Representative flow cytometry plot for mixed BM experiment. (H) Frequencies of DC progenitors and subsets in mixed BM chimera mice due to differential expression of Gramd4 SNP variant in BM, spleen, and inguinal LN. Chimerism is expressed as the ratio between the number of CD45.2 and CD45.1/CD45.2 cells for each cell population. Representative of 2 independent experiments; each dot represents one mouse, n = 6 per group, Gramd4 w/w (red) and Gramd4 sp/sp (blue), and horizontal lines represent means. (I) Schematic representation of the experimental setup in (J) and (K). (J) Representative flow cytometry plot for OT-II CD4 + T cell activation (CTV dilution after immunization with OVA 328–339 peptide in alum) in popliteal LN of Gramd4 w/w and Gramd4 sp/sp recipient mice. Graph shows the absolute numbers of OT-II cells in popliteal lymph nodes and the x axis the number of divisions after immunization. (K) CD69 and CD43 expression of divided OT-II T cells in popliteal LN of Gramd4 w/w and Gramd4 sp/sp recipient mice. Each dot represents one mouse, n = 6 per group, Gramd4 w/w (orange) and Gramd4 sp/sp (green), and horizontal lines represent means (J and K). Student’s t test, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. iLN (inguinal LN).

Journal: Cell reports

Article Title: Quantitative trait loci mapping provides insights into the genetic regulation of dendritic cell numbers in mouse tissues

doi: 10.1016/j.celrep.2024.114296

Figure Lengend Snippet: (A) Manhattan plot showing all splice variant SNPs across the 49 phenotypes. For each splice variant, the best p value observed among all assessed traits is plotted on a –log10 scale (y axis), according to its genomic coordinates (x axis). Gramd4 splice variant chosen for validation is highlighted in red. (B) Variation in frequency of BM pre-cDCs in C57BL/6J (gray; n = 3), 129 (pink; n = 3), NOD (blue; n = 3), NZO (cyan; n = 3), A/J (yellow; n = 3), WSB (purple; n = 3), DO (black; n = 170), and CC-RI (open; n = 47) mice. (C) A QTL driving the frequency of BM pre-cDCs found within chromosome 15 (chr15:86,581,607, LOD = 10.7) that appears to be driven by an A/J and NZO founder effect. (D) Gramd4 gene structure and schematic representation of alternative splicing (UCSC Genome Browser). SNP localization is shown in red. (E) Western blot on total splenocytes from Gramd4 w/w and Gramd4 sp/sp mice showing alternative splicing. (F) Schematic representation of mixed BM chimera experiment. (G) Representative flow cytometry plot for mixed BM experiment. (H) Frequencies of DC progenitors and subsets in mixed BM chimera mice due to differential expression of Gramd4 SNP variant in BM, spleen, and inguinal LN. Chimerism is expressed as the ratio between the number of CD45.2 and CD45.1/CD45.2 cells for each cell population. Representative of 2 independent experiments; each dot represents one mouse, n = 6 per group, Gramd4 w/w (red) and Gramd4 sp/sp (blue), and horizontal lines represent means. (I) Schematic representation of the experimental setup in (J) and (K). (J) Representative flow cytometry plot for OT-II CD4 + T cell activation (CTV dilution after immunization with OVA 328–339 peptide in alum) in popliteal LN of Gramd4 w/w and Gramd4 sp/sp recipient mice. Graph shows the absolute numbers of OT-II cells in popliteal lymph nodes and the x axis the number of divisions after immunization. (K) CD69 and CD43 expression of divided OT-II T cells in popliteal LN of Gramd4 w/w and Gramd4 sp/sp recipient mice. Each dot represents one mouse, n = 6 per group, Gramd4 w/w (orange) and Gramd4 sp/sp (green), and horizontal lines represent means (J and K). Student’s t test, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. iLN (inguinal LN).

Article Snippet: Gramd4 antibody _ Clone C-8 , Santa-Cruz , Cat No. sc-515128.

Techniques: Variant Assay, Biomarker Discovery, Alternative Splicing, Western Blot, Flow Cytometry, Quantitative Proteomics, Activation Assay, Expressing

KEY RESOURCES TABLE

Journal: Cell reports

Article Title: Quantitative trait loci mapping provides insights into the genetic regulation of dendritic cell numbers in mouse tissues

doi: 10.1016/j.celrep.2024.114296

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Gramd4 antibody _ Clone C-8 , Santa-Cruz , Cat No. sc-515128.

Techniques: Marker, Staining, Recombinant, Red Blood Cell Lysis, Software